HC Wainwright reiterated coverage on Otonomy with a new price target
$OTIC
Biotechnology: Pharmaceutical Preparations
Health Care
HC Wainwright reiterated coverage of Otonomy with a rating of Buy and set a new price target of $5.50 from $10.00 previously